Prestige Consumer Healthcare Inc. buy BMO Capital Markets
Start price
15.11.23
/
50%
€53.50
Target price
15.11.24
€107.78
Performance (%)
42.99%
End price
16.11.24
€76.50
Summary
This prediction ended on 16.11.24 with a price of €76.50. The BUY prediction by BMO_Capital_Markets for Prestige Consumer Healthcare Inc. saw massive gains of 42.99%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -4.717% | -4.717% | -35.669% |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% |
Comments by BMO_Capital_Markets for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten